Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1992-09-08
1994-12-06
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 514179, 514180, 514181, A61K 3156
Patent
active
053710789
ABSTRACT:
Angiostatic steroids for use in controlling ocular hypertension are disclosed. Pharmaceutical compositions of the angiostatic steroids and methods for their use in treating ocular hypertension, including controlling the ocular hypertension associated with primary open angle glaucoma, are disclosed. In addition, the combination of the compounds with glucocorticoids for the prevention of elevated IOP during the treatment of inflammation is disclosed.
REFERENCES:
patent: 4863912 (1989-09-01), Southren et al.
patent: 4975537 (1990-12-01), Aristoff et al.
patent: 5023250 (1991-06-01), Adams et al.
Clark Abbot F.
Conrow Raymond E.
Alcon Laboratories Inc.
Kestler Kimberly J.
Richter Johann
Yeager Sally
LandOfFree
Angiostatic steroids and methods and compositions for controllin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiostatic steroids and methods and compositions for controllin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiostatic steroids and methods and compositions for controllin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-214576